Autore: Morgese, Giuseppe
Titolo: Accordo TRIPs ed esclusione dalla brevettabilità di alcune invenzioni farmaceutiche in India: osservazioni in margine al caso Novartis
Periodico: Diritti umani e diritto internazionale
Anno: 2013 - Volume: 7 - Fascicolo: 2 - Pagina iniziale: 453 - Pagina finale: 464

Based on Section 3(d) of the Patents Act, on April 1st, 2013, the Indian Supreme Court has deniedthe drug company Novartis a patent on a new form of a known substance whose therapeutic efficacydid not differ significantly from the latter. In my opinion, Section 3(d), as interpreted by theSupreme Court, meets the flexible standard of Article 27 of the TRIPs Agreement, which requiresWTO Members States to grant patent protection for any inventions, provided that they are new,involve an inventive step and are capable of industrial application, but does not define what ismeant by these terms. This leaves WTO Member States a wide room of maneuver to fine-tune their(pharmaceutical) patent systems on their own needs, banning frivolous invention without preventingthe patenting of genuine incremental innovations. In addition, Section 3(d) clearly is a measuresto protect public health as reaffirmed by the 2001 Doha Declaration on TRIPs and Public Health.




SICI: 1971-7105(2013)7:2<453:ATEEDB>2.0.ZU;2-P
Testo completo: http://www.mulino.it/download/article/10.12829/74163
Testo completo alternativo: http://www.mulino.it/doi/10.12829/74163

Esportazione dati in Refworks (solo per utenti abilitati)

Biblioteche ACNP che possiedono il periodico